GADVX | HMECX | GADVX / HMECX | |
Total Expense Ratio | 1.12 | 3.14 | 36% |
Annual Report Gross Expense Ratio | 1.12 | 3.39 | 33% |
Fund Existence | 18 years | 9 years | - |
Gain YTD | 1.974 | 2.166 | 91% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 2500 | 40% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 431M | 1.09B | 39% |
Annual Yield % from dividends | 3.29 | 4.29 | 77% |
Returns for 1 year | 5.95 | 5.08 | 117% |
Returns for 3 years | 17.35 | 13.08 | 133% |
Returns for 5 years | 19.00 | 14.20 | 134% |
Returns for 10 years | 18.97 | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
NYF | 51.89 | -0.17 | -0.33% |
iShares New York Muni Bond ETF | |||
MGF | 3.07 | -0.02 | -0.65% |
MFS Government Markets Income Trust | |||
NCA | 8.42 | -0.06 | -0.72% |
Nuveen California Municipal Value Fund | |||
BBP | 60.00 | -0.56 | -0.92% |
Virtus LifeSci Biotech Products ETF | |||
FVD | 44.57 | -0.48 | -1.07% |
First Trust Value Line® Dividend ETF |